Adis LMS Alerts

Product description

In the fast-evolving world of medical market intelligence, accurate and relevant pharmacoevaluation is critical to capitalize on the challenges and opportunities of today's competitive pharmaceutical environment. The Adis LMS - the Literature Monitoring and Evaluation Service - delivers the right information, to the highest standards, at the right time in a range of print and electronic formats to meet your exact needs.

The following therapeutic areas are covered by the Adis LMS:

Affective Disorders Alzheimer's Disease / Cognition Disorders* Antibacterials Antithrombotics Antivirals Anxiety Disorders Arrhythmias Cancer Chemotherapy Diabetes Epilepsy / Seizure Disorders* Heart Failure Hyperlipidaemia Hypertension Ischaemic Heart Disease	Men's Health Nausea / Migraine Obesity Obstructive Airways Disease Pain Control Parkinson's Disease / Movement Disorders* Peptic Ulcer Disease PharmacoEconomics Psychotic Disorders Rheumatic Disease Transplant Rejection Vaccines Women's Health
* also available as a combined service - Neurological Disorders

LMS Alerts Contents

There are three principal components in each therapeutic area:

1. Summaries and Evaluations
   • in-depth analysis and evaluative reports on the significant articles of the month
   • over 600 new Summaries are written every month
   • summaries of all randomised controlled trials of drug treatments, including those only reported as abstracts
2. Literature Review - a comprehensively indexed and cross-referenced bibliographic report of all published articles in a given therapeutic area: each citation gives paper title, authors' names, and the name, page numbers and issue date of the publishing journal.
3. Perspectives - an overview of the most important and interesting studies summarised during the current month: includes brief updates on research and development drugs, and relevant market news, highlights from meetings or a special report on a topical area (available in all groupware formats, and in print).

Updating & sources

In-house subject-area and information retrieval specialists identify clinically relevant information from over 1,700 medical and scientific publications as well as from scientific conferences. The critical information is evaluated by Adis drug information experts and structured assessments of all clinical trial reports and adverse reaction case studies are prepared to allow for quick and easy review of the major drug related literature in the field. 28 Therapeutic specialties are evaluated by LMS Alerts.

How can LMS Alerts Help You?

• Brand protection - evaluation of the clinical evidence
• Product positioning support - competitive intelligence
• Strategic planning
• Drug safety profiling
• Trend analysis

Available formats

• CD-ROM
• Lotus Notes
• Intranet - Notes Domino and Adis Knowledge Bases on the Net
• Internet - Powerize
• Online, from The Dialog Corporation (Dialog and DataStar) and STN
• Print

Adis International Inc., 860 Town Center Drive, Langhorne, PA 19047. Tel: 215-741-5200; Fax: 215-741-5282.